Brief: Biogen To Introduce 28 Mg Vial At Same Price As 12 Mg Vial
March 30 (Reuters) - Biogen Inc BIIB.O: BIOGEN WILL INTRODUCE 28 MG VIAL AT SAME PRICE AS 12 MG VIAL, RESULTING IN PARITY PRICING FOR PATIENTS IN THE MAINTENANCE PHASE- SPOKESPERSON BIOGEN: DO NOT EXPECT ANY ADDITIONAL OUT-OF-POCKET COSTS FOR MAJORITY OF EXISTING SPINRAZA PATIENTS - SPOKESPERSON BIOGEN: WAC OF SPINRAZA 12 MG & 28 MG VIALS IS THE SAME AT ABOUT $152,000, WAC OF 50 MG VIAL IS ABOUT $271,000 - SPOKESPERSON Further company coverage: BIIB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biogen
See all newsHealth Rounds: Old cancer drug may help restore fertility for certain women
U.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
Biogen rises; co scales back drug programs acquired through $5.6 bln Apellis deal
Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout